MEDIA ADVISORY - CSAM-SMCA opens select sessions of its 2024 scientific conference to members of the media
HAMILTON, ON, Nov. 8, 2024 /CNW/ - On Friday, November 15 media are invited to the following sessions featuring international and Canadian innovators in addiction medicine at the Hamilton Convention Centre (1 Summers Lane, Hamilton, ON):
Panel discussion: Novel therapies for substance use disorders (8:30-10:30 a.m.)
The Potential for Psychedelics in Recovery
Dr. Harriet de Witt, Professor of Psychiatry and Behavioral Neuroscience, University of Chicago (USA)
Neuromodulation as a treatment for addiction
Dr. Tony George, Professor in Psychiatry, University of Toronto and Clinical Director of the Schizophrenia program at the Centre for Addiction and Mental Health (Canada)
Wearables and mobile phone apps in prevention and harm reduction
Dr. Matthew Keough, Assistant Professor in the Department of Psychology, York University (Canada)
Understanding and addressing intimate partner violence (IPV) in the context of substance use (10:30 a.m.- 12 p.m.)
ADVANCE-D is unique program offered to men in the UK through drug and alcohol services and the criminal justice system. Support is also offered to their current or former partners. Initial findings show the program delivers considerable reductions in abusive behaviours.
Dr. Gail Gilchrist, Professor of Addictions Healthcare Research, King's College London (UK)
Dr. Liz Gilchrist, Professor of Psychological Therapies, University of Edinburgh (Scotland)
Stories from the journey of recovery (1-3 p.m.)
This session will delve into the personal story of an individual with lived experience in opioid use who is now in recovery.
Moderator: Ainko Ramanathan, RPh MPharm PharmD, Niagara Health System
Examining Buprenorphine in Different Settings (1-3 p.m.)
This session discusses a study that evaluated opioid agonist treatment retention using standard induction vs. rapid induction onto injectable buprenorphine extended release medication in participants who frequently inject opioids or use fentanyl/high doses of opioids.
Dr. Bernard Le Foll, Senior Scientist, Centre for Addiction and Mental Health (Canada)
Dr. Hannu Alho, Professor of Addiction Medicine, University of Helsinki (Finland)
Dr. Rajinder Shiwach, Psychiatrist, Insite Clinical Research (USA)
Dr. Robert Dobbins, Physician/Scientist, Indivior Inc. (USA)
Media availability: these speakers are available for interviews in-person at the conference or by phone.
Note: Conference sessions are not offered virtually.
CSAM-SMCA (csam-smca.org) is a national society of medical professionals and scientists committed to helping Canadians understand and recover with dignity from substance use disorders.
SOURCE Canadian Society of Addiction Medicine
Upcoming Life Sciences Events
- January 2025
- San Francisco: 8th Annual Neuroscience Innovation Forum
- San Francisco: RESI JPM 2025
- San Francisco: Biotech Showcase™
Latest company news
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement